Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Go back to Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
(NASDAQ: PLRX) Delayed: 1.11 -0.02 (1.77%)
Previous Close $1.13    52 Week High
Open $1.13    52 Week Low
Day High $1.13    P/E N/A 
Day Low $1.09    EPS
Volume 438,690